Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. PIMA541850

Invitrogen™ Tucotuzumab Humanized Recombinant Human Monoclonal Antibody
GREENER_CHOICE

Catalog No. PIMA541850
Change view
Click to view available options
Quantity:
100 μg
Catalog No. Quantity
PIMA541850 100 μg
1 options
This item is not returnable. View return policy

Catalog No. PIMA541850

Supplier: Invitrogen™ MA541850

Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy

Description

Human Recombinant Monoclonal Antibody

Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for one week. Store at -20 to -80 °C for twelve months from the date of receipt.

Tucotuzumab celmoleukin is under investigation in clinical trial NCT00016237 (Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment).
TRUSTED_SUSTAINABILITY

Specifications

Antigen Tucotuzumab Humanized
Applications ELISA, SDS-Page
Classification Recombinant Monoclonal
Concentration 3.4 mg/mL
Conjugate Unconjugated
Formulation PBS with no preservative; pH 7.4
Gene Alias 4-IL-2; EMD 273066; huKS1; huKS-IL2; KSA-Interleukin-2
Host Species Human
Immunogen Human EPCAM/CD326.
Purification Method Protein A
Quantity 100 μg
Regulatory Status RUO
Primary or Secondary Primary
Target Species Human
Content And Storage -20°C, Avoid Freeze/Thaw Cycles
Product Type Antibody
Form Liquid
Isotype IgG1
Target Molecule Chemical
Show More Show Less

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.